Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.
At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All Health Conditions. | All Health Conditions. Area of Focus: Transfusions of blood products. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of transfusions per participant | Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions | participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of transfusion of any blood product per participant | Count of any blood products per case, QM Data | participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years |
| Cost of any blood product per participant |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All cases of all in hospital patients. Area of Focus: Transfusions of blood products.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Donat R Spahn, Prof | IFA University Hospital Zurich | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Zurich | Zurich | 8091 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D006470 | Hemorrhage |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
costs per case |
| participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years |
| Survey of Patient Blood Management System | clinical, financial,and administrative data of all participants will be reviewed on the focus on transfusions | participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years |